Sanofi, a French drugmaker will make 30 of its treatments, including insulin, available on a not-for-profit basis in 40 lower-income countries. This will be the first step of Sanofi’s plan to increase access to its medicines worldwide.
Sanofi said that this plan also involves the $25 million impact fund, which will go towards encouraging local start-up healthcare businesses and offer training on using the medicines.
Jon Fairest, who heads the global health unit, said that there’s a lot of noise at the moment from various companies jumping into this space, however, investing in entrepreneurship in the ecosystem is a new thing.
